"
Team:Freiburg
From 2013.igem.org
(Difference between revisions)
| Line 383: | Line 383: | ||
<div id="text_gross" align="left"> <a style="position:absolute; top:678px; left:910px; z-index:2" href="https://2013.igem.org/Team:Freiburg/News"> News </a></div> | <div id="text_gross" align="left"> <a style="position:absolute; top:678px; left:910px; z-index:2" href="https://2013.igem.org/Team:Freiburg/News"> News </a></div> | ||
| - | <img src="https://static.igem.org/mediawiki/2013/3/33/Lyon_logo-Freiburg-2013.png" height=" | + | <img src="https://static.igem.org/mediawiki/2013/3/33/Lyon_logo-Freiburg-2013.png" height="100" style="position:absolute; top:703px; left:910px; z-index:1"> |
</div> | </div> | ||
<img id="klammer_klein_rechts" src="https://static.igem.org/mediawiki/2013/8/82/Freiburg_2013_main2_Rahmen_gross_rechts.png"> | <img id="klammer_klein_rechts" src="https://static.igem.org/mediawiki/2013/8/82/Freiburg_2013_main2_Rahmen_gross_rechts.png"> | ||
Revision as of 21:44, 16 October 2013
Our Team developed a universal toolkit, termed uniCAS, that enables customizable gene
regulation in mammalian cells. Therefore, we engineered the recently understood and highly promising
CRISPR/Cas9 system.
The regulation is based on the RNA-guided dCas9 protein, which allows targeting of specific DNA sequences. Our toolkit comprises not only a standardized dCas9 protein, but also different effector domains for efficient gene activation or repression. 
|
|
|
|
|
|
|
